These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 26463638)
1. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60). Kachalaki S; Baradaran B; Majidi J; Yousefi M; Shanehbandi D; Mohammadinejad S; Mansoori B Biomed Pharmacother; 2015 Oct; 75():100-4. PubMed ID: 26463638 [TBL] [Abstract][Full Text] [Related]
2. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells. Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide. Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469 [TBL] [Abstract][Full Text] [Related]
4. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells. Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801 [TBL] [Abstract][Full Text] [Related]
5. Silencing of myeloid cell leukemia-1 by small interfering RNA improves chemosensitivity to etoposide in u-937 leukemic cells. Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Karimi P; Othman F J Biol Regul Homeost Agents; 2016; 30(1):55-65. PubMed ID: 27049076 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells. Lin M; Hu J; Liu T; Li J; Chen B; Chen X Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237 [TBL] [Abstract][Full Text] [Related]
7. Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression. Liang R; Chen XQ; Bai QX; Wang Z; Zhang T; Yang L; Dong BX; Gao GX; Gu HT; Zhu HF Acta Haematol; 2014; 132(2):177-86. PubMed ID: 24603438 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis. Xu K; Zhuang XX; Shi XW Expert Rev Hematol; 2024; 17(1-3):87-94. PubMed ID: 38230679 [TBL] [Abstract][Full Text] [Related]
9. [Regulatory effect of small interfering RNA targeting multidrug resistant protein 1 on chemosensitivity of human multiforme glioblastoma cell line BT325]. Zhao P; Zhang YZ; Sun MZ Ai Zheng; 2005 Dec; 24(12):1436-41. PubMed ID: 16351788 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia. Jafarlou M; Shanehbandi D; Dehghan P; Mansoori B; Othman F; Baradaran B Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1792-1798. PubMed ID: 29113504 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. Duan Z; Brakora KA; Seiden MV Mol Cancer Ther; 2004 Jul; 3(7):833-8. PubMed ID: 15252144 [TBL] [Abstract][Full Text] [Related]
12. Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells. Baradaran B; Nazmabadi R; Ariyan Z; Sakhinia E; Karami H Asian Pac J Cancer Prev; 2022 Jul; 23(7):2523-2530. PubMed ID: 35901361 [TBL] [Abstract][Full Text] [Related]
13. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cioca DP; Aoki Y; Kiyosawa K Cancer Gene Ther; 2003 Feb; 10(2):125-33. PubMed ID: 12536201 [TBL] [Abstract][Full Text] [Related]
14. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA. Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells. Feng R; Dong L Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488 [TBL] [Abstract][Full Text] [Related]
16. siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells. Montazami N; Kheir Andish M; Majidi J; Yousefi M; Yousefi B; Mohamadnejad L; Shanebandi D; Estiar MA; Khaze V; Mansoori B; Baghbani E; Baradaran B Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):98-103. PubMed ID: 26025411 [TBL] [Abstract][Full Text] [Related]
17. Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA. Li L; Xu J; Min T; Huang W Eur J Pharmacol; 2006 Apr; 536(1-2):93-7. PubMed ID: 16564522 [TBL] [Abstract][Full Text] [Related]
18. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046 [TBL] [Abstract][Full Text] [Related]
19. Reversal of MDR1 gene-dependent multidrug resistance in HL60/HT9 cells using short hairpin RNA expression vectors. Shao SL; Zhang WW; Li XY; Zhang ZZ; Yun DZ; Fu B; Zuo MX Cancer Biother Radiopharm; 2010 Apr; 25(2):171-7. PubMed ID: 20423230 [TBL] [Abstract][Full Text] [Related]
20. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer]. Tang J; Cao L; Yi H; Tang C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]